The tryptophan metabolites can contribute to the modulation of intestinal immune cells and barrier functions via activating aryl hydrocarbon receptor (AHR), which is involved in the inflammatory bowel disease (IBD) pathogenesis 121–123. This evidence concerns the gene AHR and inflammatory bowel disease.